InceptionR’s Theravance Biopharma TBPH Stock Holding History

InceptionR’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-17,435	Closed	-$148K	–	862
2024 Q2	$148K	Buy	+17,435	New	+$157K	0.04%	532

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

InceptionR's TBPH Position: Q3 2024 in Review

InceptionR sold out of Theravance Biopharma (TBPH) in Q3 2024, closing a stake of 17,435 shares — an estimated $148K sold.

InceptionR first reported a position in TBPH in Q2 2024 and held it in 1 quarter. The position peaked at $148K in Q2 2024. 119 funds tracked by Wall St. Rank hold TBPH as of Q3 2024.

InceptionR reported no remaining Theravance Biopharma position as of Q3 2024 after selling out during the quarter.
InceptionR sold 17,435 Theravance Biopharma shares in Q3 2024, an estimated $148K.
InceptionR first reported a position in Theravance Biopharma in Q2 2024 and held it in 1 quarter.
InceptionR's Theravance Biopharma position peaked at $148K in Q2 2024.
119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2024.

Based on InceptionR's 13F filing for Q3 2024, filed 8 Nov 2024.